Unknown

Dataset Information

0

Molecular mechanism of viomycin inhibition of peptide elongation in bacteria.


ABSTRACT: Viomycin is a tuberactinomycin antibiotic essential for treating multidrug-resistant tuberculosis. It inhibits bacterial protein synthesis by blocking elongation factor G (EF-G) catalyzed translocation of messenger RNA on the ribosome. Here we have clarified the molecular aspects of viomycin inhibition of the elongating ribosome using pre-steady-state kinetics. We found that the probability of ribosome inhibition by viomycin depends on competition between viomycin and EF-G for binding to the pretranslocation ribosome, and that stable viomycin binding requires an A-site bound tRNA. Once bound, viomycin stalls the ribosome in a pretranslocation state for a minimum of ? 45 s. This stalling time increases linearly with viomycin concentration. Viomycin inhibition also promotes futile cycles of GTP hydrolysis by EF-G. Finally, we have constructed a kinetic model for viomycin inhibition of EF-G catalyzed translocation, allowing for testable predictions of tuberactinomycin action in vivo and facilitating in-depth understanding of resistance development against this important class of antibiotics.

SUBMITTER: Holm M 

PROVIDER: S-EPMC4743798 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular mechanism of viomycin inhibition of peptide elongation in bacteria.

Holm Mikael M   Borg Anneli A   Ehrenberg Måns M   Sanyal Suparna S  

Proceedings of the National Academy of Sciences of the United States of America 20160111 4


Viomycin is a tuberactinomycin antibiotic essential for treating multidrug-resistant tuberculosis. It inhibits bacterial protein synthesis by blocking elongation factor G (EF-G) catalyzed translocation of messenger RNA on the ribosome. Here we have clarified the molecular aspects of viomycin inhibition of the elongating ribosome using pre-steady-state kinetics. We found that the probability of ribosome inhibition by viomycin depends on competition between viomycin and EF-G for binding to the pre  ...[more]

Similar Datasets

| S-EPMC3518269 | biostudies-literature
| S-EPMC7229676 | biostudies-literature
| S-EPMC4412071 | biostudies-literature
| S-EPMC3034019 | biostudies-literature
| S-EPMC3187005 | biostudies-literature
| S-EPMC6594751 | biostudies-literature
| S-EPMC7948499 | biostudies-literature
| S-EPMC4614984 | biostudies-literature
| S-EPMC10491241 | biostudies-literature
| S-EPMC5880122 | biostudies-literature